0% found this document useful (0 votes)
101 views26 pages

G Sundar Pharmqa Compliance Services India

Download as pdf or txt
Download as pdf or txt
Download as pdf or txt
You are on page 1/ 26

WELCOME

Title:: Effective GMP AUDITS for


APIs and Formulation Pharma
Companies
By
G.Sundar-Director/Consultant
PharmQA Compliance solutions
Contents:
 Introduction
 GMP Audit
 GMP Audit plan
 GMP Auditing Techniques
 Assessing GMP compliance GAP
 GMP Audit Report
 CAPA Plan for compliance.
 Regulatory Guidance references
GMP Audit
 Introduction:
 The independent third-party GMP audit is to evaluate
GMP compliance status of the manufacturer in
accordance with the current GMP requirements set
forth in 21 CFR Part 210 & 211 ICH Q7 and EU GMP
with its interpretations.
 The compliance status will be evaluated in terms of
Quality compliance with respect to all the six GMP
systems and hardware, software, and personnel. All
deficiencies identified during the cGMP audits will be
noted in the audit report with gap analysis and
proposed corrective actions
GMP Audit Definition
 GMP inspection: on-site assessment of the
compliance with the GMP principles performed by
officials of competent authorities or authorities found
equivalent (Qualified inspectors).

 A systematic, independent and documented process


for obtaining evidence and evaluating it objectively to
determine the extent to which criteria are fulfilled.
GMP audit Related definition:
 Auditee : Persons from an organisation or organisational unit
being audited.
 Auditor: A Qualified person with the competence to conduct
an audit.
 Audit Team :One or more auditors conducting an audit. Audit
Unit An organisation or organisational unit (e.g. departments,
plants, sites) to be audited.
 Audit Communication :Is a process of exchanging information
between two or more persons. Communication can be verbal
and/or other means
 Competence :The demonstrated ability to apply knowledge and
skills.
 Compliance: GMP Applying to national/international GMP
regulations. Compliance, regulatory Applying to statements
made in the organisations own documents submitted to the
authorities.
GMP Audit Benefits:
-The following benefits to the Pharmaceutical industry:
 Effective assessment of GMP Compliance
 Reduced costs
 Improved performance
 Facilitating harmonised guidelines for auditing
 Increased external confidence
 Inspection readiness Trouble free operation.
GMP Audit process:
 Following this document will provide the current “state of
the art” in pharmaceutical auditing.
 Before the Audit:-Audit communication to understand
the know how about the firm to be audited
 Pre-Audit Questionnaire Document requesting general
information for the preparation of the auditors.
 Audit plan: Gives a general overview of the audit units, the
frequency in which the audit units ought to be audited and
provides a summary of the audit units to be conducted
 Audit schedule: Fixed dates at which the audit will take
place for a pre-defined timeframe (usually a year). If not
too complex, the Audit Plan and Audit Schedule can be
combined to one document
GMP Audit process
 Letter announcing/requesting the audit :The auditee
must be given the chance to organise himself. For this
reason the auditor(s) should seek for an invitation well in
advance of the planned/scheduled audit. This may be in
form of a letter (mostly external) or memo (mostly
internal) or even by e-mail.
 Audit agenda: An agenda agreed between auditor(s) and
auditee, defining the topics to be focused and/or audited
units.
 Secrecy agreement : (CDA/NDA): It is advisable to sign a
secrecy agreement for external audits (supplier,
contractor). Most often the auditor will be taken into
sensitive areas, where a knowledge transfer, caused by the
auditor, could lead to competitive disadvantages.
GMP Audit process
 Conduct of GMP audit:
 The compliance status will be evaluated in terms of Quality
compliance with respect to all the six systems and hardware,
software, and personnel.
 All deficiencies identified during the cGMP audits will be noted
in the audit report with gap analysis and proposed corrective
actions. A pharmaceutical auditing process may include review
of the following
 Documentation and Record Control
 Verification of data integrity and its control measures
 Manufacturing Process and Equipment
 Training
 Validation and Qualification
GMP Audit process:
 Audit report: A detail report of audit report shall be
prepared and sent to the Firm for CAPA
 Response to audit report: A detail response letter
from firm to the auditing agency with actions taken,
CAPA details with covering letter sent to the regulatory
agency.
 GMP Certificate/compliance: Statement: certificate
with validity period and a statement of GMP
compliance will be issued to the firm after satisfactory
audit response letter.
 Monitoring: The firm internally monitoring the
compliance status in their Quality meetings
GMP Audit Agenda (Plan):
 Firm details
 Objective
 Scope
 Schedule with period of audit
 Auditor information
 Supporting Documentation
 Assessment standards
 Audit process with proposed areas
 Concluding meeting requirements
 Audit arrangement requirements.
GMP Auditing Techniques
 Introduction

 Introduction of Company management and its facility
 Brief introduction of consultancy services
 Discussion of audit objective, plans, and schedule
 Overview of general site and facilities design and layout
 Facility tour of receiving, storage, sampling, dispensing, manufacturing,
packaging, warehousing and shipping areas, following with material and
personnel flow.
 QC Laboratory tour and microbial laboratory
 Quality systems: management review, documentation system, internal
audit, training, change control, deviation management, Risk assessment
validation approach, corrective and preventive action.
 Data Integrity in QC;QA and Production; Stores; Engineering.
 Environmental monitoring review
 Calibration and maintenance program
 Validation master plan and reports review
 Complaints and recall management
GMP Auditing Techniques
 We request availability of the following reference and discussion
materials during the course of this audit: but not limited to.
 Site Master File and/or Quality Manual
 GMP, manufacturing, ISO or other certification
 List of products manufactured at the site
 Current Organisation Chart for the site.
 Facility floor plans
 Procedures to prevent mix-up in production and packaging
 Plans of Air handling (HVAC), Compressed air system, and any
other service systems supporting packaging.
 Index of SOPs.
 Job descriptions for Key personnel
GMP Auditing techniques
 Training schedule and records
 Change Control
 Procedures for rework/reprocessing
 Recording of deviations and follow up
 Annual Product Review SOP
 Validation Master Plan for the site
 Validation Reports
 Qualification/Validation Reports for production equipment and areas
 Cleaning Validation Reports for equipment and areas used for production
 Starting material, in-process material and finished goods specifications and testing
procedures
 Register for deviations
 Risk assessment
 Environmental monitoring summaries (trending) for packaging areas used for packaging
 Procedures, systems and reporting on audits to be conducted by firm for their suppliers,
 Vendor certification procedure for suppliers of materials used in manufacturing and
packaging.
 Internal audit schedule
 Handling of complaints and recalls
 Calibration Program
 Preventative Maintenance Program
GMP Auditing Techniques
 5 W and one H method-Who ,what, when, where, why
and how?
 Interviewing/Interrogation
 Reviewing recorded information against raw data
 Analysing data and information against compliance
Assessing GMP compliance GAP

 Availability (and if necessary translations) of key


documents
 Assessment of Team on co-ordinate preparations and
answers
 Composition, organisation and responsibilities of the team
 Availability of key staff, and involvement of senior and/or
top management (provide correct partner for discussions)
 Training of staff in what to expect, and how to respond to
an auditor's questions
 Data integrity and its compliance
Audit observations and its
classification
Audit report
 Upon completion of the audit, the lead auditor will compile
the findings and provide the section representatives with a
preliminary report. This preliminary report is a synopsis of
the findings and provides section personnel with an
opportunity to voice any objections. If valid objections are
raised, the audit team should adjust their findings
accordingly.
 lead auditor assimilates all data from the audit and
prepares an audit summary report. After receipt of this this
audit report, CAPA actions and follow-up activities are
discussed and a response letter will be prepared by firm.
CAPA plan for compliance
 The firm QMS Manager assimilates all data from the audit and
prepares an audit summary report. The audit report, corrective actions
and follow-up activities are discussed [Frequency (e.g. weekly)] during
management meetings.

 Resolution report of corrective actions taken and follow-up activities is


prepared by the QMS Manager through the [Name] to the [Name] and
staff

 In the event, the audit identifies a problem associated with incorrect


procedures, invalid action or invalid data, immediate corrective action
will be taken. The QMS Manager will notify the [Name] to determine
the most efficient method of notifying the client (i.e. by telephone,
email, fax or letter). This notification will be documented. Corrected
reports will be issued.

 A detailed Response letter citing the CAPA evidence will be sent to the
agency
Auditor Qualification
 Auditors should have sufficient scientific, technical and other
experience to enable them to perform an adequate and thorough audit
of the active substance/formualation manufacturer, as related to the
planned scope of the audit.
 Where a proposed auditor lacks an appropriate level of direct
experience in the field of active substance manufacture, he or she
should undergo a documented training and assessment programme in
the areas that are relevant to the audit, taking into account the
auditor’s anticipated role in the audit and the technologies that are
likely to be encountered during the audit.
 Auditors must also be trained and assessed in their knowledge and
understanding of EU GMP and in auditing techniques in general. The
training and assessment should be fully documented.
 The qualification and experience of contracted auditors are the same as
the requirements for the manufacturing-authorisation holder’s own
auditors.
APIC Guide
 Companies should have an internal scheme setting the
criteria to qualify as auditor and to maintain this
qualification status.
 Typically this would be :
 Active involvement in a GMP related activity
preferably for a minimum of two years
 Have participated in at least three audits as auditee
 Have followed an auditor training programme for
example the APIC Certified Auditor Training course
that is organised by the API Compliance Institute
 Conducts at least one audit per year
References:
 Thanks for your Attention and any questions?

You might also like